Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J van Eggermond

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
International Journal of Immunogenetics|March 7, 2012
Type III bare lymphocyte syndrome associated with a novel RFXAP mutation: a case reportB Gokturk, H Artac, M J van Eggermond, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 1999
Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5A Peijnenburg, M J Van Eggermond, S J Gobin, et al.
Immunogenetics|February 9, 2000
Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator geneA Peijnenburg, R Van den Berg, M J Van Eggermond, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
International Journal of Immunogenetics|March 7, 2012
Type III bare lymphocyte syndrome associated with a novel RFXAP mutation: a case reportB Gokturk, H Artac, M J van Eggermond, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 1999
Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5A Peijnenburg, M J Van Eggermond, S J Gobin, et al.
Immunogenetics|February 9, 2000
Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator geneA Peijnenburg, R Van den Berg, M J Van Eggermond, et al.
Pageof 1